Chlorambucil-conjugated PI-polyamides (Chb-M’), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation

[1] D.J. Shih, P.A. Northcott, M. Remke, A. Korshunov, V. Ramaswamy, M. Kool,

B. Luu, Y. Yao, X. Wang, A.M. Dubuc, L. Garzia, J. Peacock, S.C. Mack, X. Wu,

A. Rolider, A.S. Morrissy, F.M. Cavalli, D.T. Jones, K. Zitterbart, C.C. Faria,

U. Schuller, L. Kren, T. Kumabe, T. Tominaga, Y. Shin Ra, M. Garami, P. Hauser,

J.A. Chan, S. Robinson, L. Bognar, A. Klekner, A.G. Saad, L.M. Liau, S. Albrecht,

A. Fontebasso, G. Cinalli, P. De Antonellis, M. Zollo, M.K. Cooper, R.C. Thompson,

S. Bailey, J.C. Lindsey, C. Di Rocco, L. Massimi, E.M. Michiels, S.W. Scherer,

J.J. Phillips, N. Gupta, X. Fan, K.M. Muraszko, R. Vibhakar, C.G. Eberhart,

M. Fouladi, B. Lach, S. Jung, R.J. Wechsler-Reya, M. Fevre-Montange, A. Jouvet,

N. Jabado, I.F. Pollack, W.A. Weiss, J.Y. Lee, B.K. Cho, S.K. Kim, K.C. Wang,

J.R. Leonard, J.B. Rubin, C. de Torres, C. Lavarino, J. Mora, Y.J. Cho, U. Tabori,

J.M. Olson, A. Gajjar, R.J. Packer, S. Rutkowski, S.L. Pomeroy, P.J. French,

N.K. Kloosterhof, J.M. Kros, E.G. Van Meir, S.C. Clifford, F. Bourdeaut, O. Delattre,

F.F. Doz, C.E. Hawkins, D. Malkin, W.A. Grajkowska, M. Perek-Polnik, E. Bouffet,

J.T. Rutka, S.M. Pfister, M.D. Taylor, Cytogenetic prognostication within medulloblastoma subgroups, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 32 (2014)

886e896, https://doi.org/10.1200/JCO.2013.50.9539.

[2] B.L. Holgado, A. Guerreiro Stucklin, L. Garzia, C. Daniels, M.D. Taylor, Tailoring

medulloblastoma treatment through genomics: making a change, one subgroup at a time, Annu. Rev. Genom. Hum. Genet 18 (2017) 143e166, https://

156

Y. Matsui, Y. Mineharu, Y. Noguchi et al.

Biochemical and Biophysical Research Communications 620 (2022) 150e157

https://doi.org/10.1038/s41586-019-1186-3.

[17] Y. Kamikubo, Genetic compensation of RUNX family transcription factors in

leukemia, Canc. Sci. 109 (2018) 2358e2363, https://doi.org/10.1111/

cas.13664.

[18] W.A. Freed-Pastor, C. Prives, Mutant p53: one name, many proteins, Genes

Dev. 26 (2012) 1268e1286, https://doi.org/10.1101/gad.190678.112.

D.A. Porter, M.D. Jones, J. Golji, G. Caponigro, J.E. Taylor, C.M. Dunning,

A.L. Creech, A.C. Warren, J.M. McFarland, M. Zamanighomi, A. Kauffmann,

N. Stransky, M. Imielinski, Y.E. Maruvka, A.D. Cherniack, A. Tsherniak,

F. Vazquez, J.D. Jaffe, A.A. Lane, D.M. Weinstock, C.M. Johannessen,

M.P. Morrissey, F. Stegmeier, R. Schlegel, W.C. Hahn, G. Getz, G.B. Mills,

J.S. Boehm, T.R. Golub, L.A. Garraway, W.R. Sellers, Next-generation characterization of the cancer cell line Encyclopedia, Nature 569 (2019) 503e508,

157

...